News > After Pfizer, Serum Institute Seeks Emergency Use Nod for Vaccine in India

After Pfizer, Serum Institute Seeks Emergency Use Nod for Vaccine in India

The Serum Institute of India on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford COVID-19 vaccine in the country.

A day earlier, the Indian arm of US pharmaceutical giant Pfizer became the first to seek a similar approval from India’s drug regulator for its own COVID-19 vaccine in the country, after securing such clearance in the UK and Bahrain.